Print Page  Close Window

Investor Relations

Overview

Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$12.15 - 0.2
Stock chart for: ZGNX.O.  Currently trading at $12.15 with a 52 week high of $15.19 and a 52 week low of $7.33.
Data as of 12/09/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Latest Presentations

Zogenix November 2016 Investor Presentation
Download Documentation

Recent News More

Zogenix Announces New Efficacy and Safety Data for ZX008 in Treatment of Seizures in Lennox Gastaut Syndrome & Dravet Syndrome

Read More

Zogenix to Participate in Oppenheimer Life Sciences Summit 2016

Read More

Investor Events More